Hanjiao Qin
- Physiology top 10%
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 3
-
- Endoplasmic Reticulum Stress and Disease 2
-
- Autophagy in Disease and Therapy 4
-
- Cancer Mechanisms and Therapy 3
-
- Traditional Chinese Medicine Analysis 2
-
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Jiyao ShengXuewen ZhangYe XuBingjin LiLiu ShuiChunyan YuJinsong KangHongyan Li
- Partner nations
- China
In The Last Decade
Hanjiao Qin
21 papers receiving 611 citations
Peers
Comparison fields: 5 of 84
- Physiology 37
- Cancer Research 98
- Molecular Biology 304
- Cell Biology 67
- Epidemiology 142
Countries citing papers authored by Hanjiao Qin
This map shows the geographic impact of Hanjiao Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanjiao Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanjiao Qin more than expected).
Fields of papers citing papers by Hanjiao Qin
This network shows the impact of papers produced by Hanjiao Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanjiao Qin. The network helps show where Hanjiao Qin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hanjiao Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 32 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 5 | |
| 12 | 2019 | 65 | |
| 13 | 2018 | 42 | |
| 14 | 2017 | 98 | |
| 15 | 2015 | 50 | |
| 16 | 2015 | 4 | |
| 17 | 2013 | 21 | |
| 18 | 2011 | 138 | |
| 19 | 2011 | 21 | |
| 20 | 2011 | 12 |
About Hanjiao Qin
Hanjiao Qin is a scholar working on Physiology, Cancer Research and Complementary and alternative medicine, having authored 23 papers that have together received 618 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (4 papers), Cancer Mechanisms and Therapy (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Traditional Chinese Medicine Analysis (2 papers), MicroRNA in disease regulation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Physiology (37 citations), Cancer Research (98 citations) and Molecular Biology (304 citations). Hanjiao Qin has collaborated with scholars based in China. Frequent co-authors include Jiyao Sheng, Xuewen Zhang, Ye Xu, Bingjin Li, Liu Shui, Chunyan Yu, Jinsong Kang, Hongyan Li, Linlin Liu and Jing Su. Their work appears in journals such as Advanced Science, Cancer Letters and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.